生命科学资讯

European Commission unveils EU Biotech Act as it lags behind other countries

Senate passes Biosecure Act aimed at Chinese suppliers

RFK Jr. adds conditions to newborn screening list after committee termination

CDC stops recommending universal hepatitis B birthdose

Several companies expected to announce ‘most favored nation’ deals Friday at White House

RTW's Yarrow to go public in reverse merger with Vyne Therapeutics

Novo Nordisk hit with FDA warning letter over acquired Catalent factory

Vir licensing deal; Cytokinetics wins China nod; Vistagen's social anxiety fail

AI biotech preview of 2026: Clinic takes center stage

Post-Hoc Live: Endpoints winners and losers list for 2025

Hansa’s enzyme therapy flunks Phase 3 trial in rare kidney disease

GSK wins FDA approval for long-acting asthma drug

Harbour makes $90M upfront deal with Bristol Myers for new antibodies

DBV charts new path to market peanut allergy patch after Phase 3 success

Makary walks back talk of Covid-19 vaccine risk amid internal FDA debate

Verge Genomics' ALS drug fails as biotech shifts to partner model

Mythic Therapeutics shuts down, ends ADC trial as funding dries up

Nektar's immunology drug misses in Phase 2b, execs cite enrollment errors

Pfizer bets big on obesity to offset major patent cliff

J&J backs financing round for Stanford CAR-T cell therapy spinout Link Cell